PRCT (STOCKS)
PROCEPT BioRobotics Corporation Common Stock
$23.460000
+0.260000 (+1.12%)
Prev close: $23.200000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Larry L. Wood
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,322.91M
- Employees
- 756
- P/E (TTM)
- -13.49
- P/B (TTM)
- 3.57
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
10
Buy
5
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.53 | $-0.33 | -0.1993 | -60.27% |
|
Sep 2025 (Q3)
|
$-0.38 | $-0.42 | +0.0398 | +9.48% |
|
Jun 2025 (Q2)
|
$-0.35 | $-0.42 | +0.0731 | +17.28% |
|
Mar 2025 (Q1)
|
$-0.45 | $-0.50 | +0.0498 | +9.96% |
Financial Statements
| Revenues | $308.05M |
| Benefits Costs and Expenses | $403.44M |
| Cost Of Revenue | $111.83M |
| Costs And Expenses | $403.44M |
| Gross Profit | $196.23M |
| Operating Expenses | $300.09M |
| Selling, General, and Administrative Expenses | $228.81M |
| Research and Development | $71.28M |
| Operating Income/Loss | -$103.86M |
| Income/Loss From Continuing Operations After Tax | -$95.57M |
| Income/Loss From Continuing Operations Before Tax | -$95.38M |
| Income Tax Expense/Benefit | $190.00K |
| Net Income/Loss | -$95.57M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$95.57M |
| Net Income/Loss Available To Common Stockholders, Basic | -$95.57M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.72 |
| Diluted Earnings Per Share | -$1.72 |
| Basic Average Shares | 55,544,000 |
| Diluted Average Shares | 55,544,000 |
| Assets | $508.08M |
| Current Assets | $450.38M |
| Inventory | $70.69M |
| Other Current Assets | $379.68M |
| Noncurrent Assets | $57.70M |
| Fixed Assets | $30.40M |
| Other Non-current Assets | $27.30M |
| Liabilities | $142.21M |
| Current Liabilities | $65.80M |
| Accounts Payable | $17.29M |
| Other Current Liabilities | $48.51M |
| Noncurrent Liabilities | $76.42M |
| Long-term Debt | $51.62M |
| Other Non-current Liabilities | $24.80M |
| Equity | $365.87M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $365.87M |
| Liabilities And Equity | $508.08M |
| Net Cash Flow From Operating Activities | -$48.99M |
| Net Cash Flow From Operating Activities, Continuing | -$48.99M |
| Net Cash Flow From Investing Activities | -$9.36M |
| Net Cash Flow From Investing Activities, Continuing | -$9.36M |
| Net Cash Flow From Financing Activities | $11.19M |
| Net Cash Flow From Financing Activities, Continuing | $11.19M |
| Net Cash Flow | -$47.15M |
| Net Cash Flow, Continuing | -$47.15M |
| Comprehensive Income/Loss | -$95.65M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$95.65M |
| Other Comprehensive Income/Loss | -$95.65M |